FormFactor surged on an Nvidia probe-card qualification and a Buy initiation while the pure-plays went quiet and cryogenics slipped.

FormFactor (FORM) led the vertical, up 9.6% to $149.31 — within reach of its 52-week high — on a double catalyst. Deutsche Bank initiated coverage with a Buy rating and a $200 price target, and the company was confirmed as a second qualified probe-card supplier for Nvidia GPUs manufactured at TSMC. The near-term driver is AI accelerator demand, but the move reinforces FORM's grip on the test-and-measurement chokepoint this vertical maps: FORM supplies the cryogenic probe cards and characterization hardware that any scaled qubit-fabrication line leans on to screen devices at millikelvin and wafer level. A second-source win at the industry's dominant customer deepens that moat.

The laggard was Sumitomo Heavy Industries' ADR (SOHVY), down 2.9% to $9.46 on no company-specific news. Sumitomo sits on the cryogenics rung — its Gifford-McMahon cryocoolers and compressors are a binding constraint for the superconducting and trapped-ion platforms that require sub-kelvin environments — so the move is worth watching, but a sub-3% drift in that name's last session is beta, not a demand signal.

Away from those two, the session's message was that capital chased the enabling-hardware story, not quantum optionality. The gate-model pure-plays were quiet to mixed after last week's selloff: D-Wave +0.9% to $16.57, IonQ −0.1% to $43.86, Rigetti flat at $15.74. The photonics-and-equipment rung was mixed — Coherent −1.5% to $287.81, Keysight +0.9% to $364.04, Applied Materials roughly flat at $511.38 — while Intel rose 3.7% to $120.23 on the foundry-and-compute adjacency. The clearest red was in smaller enabling and isotope names: Infleqtion −2.7% to $13.47 and Silex's ADR −2.4% to $14.75. On a Q3-close tape that saw the Nasdaq eke out a 0.2% gain, the probe-card name's AI-driven pop stood apart from a flat quantum complex.

The policy and conference calendar is the near-term swing factor. The National Quantum Initiative Reauthorization Act is moving toward floor action — the federal funding backbone for the field. DARPA's Quantum Benchmarking Initiative is the harder catalyst: Stage B concludes in early November with the Stage C down-select window running through December, the government's own verdict on which architectures are credible. Q2B26 Chicago (Dec 8–10) is the year-end industry showcase, and ASP Isotopes' first commercial silicon-28 shipments, guided to Q3 2026, would validate the isotopically-pure-substrate rung that silicon-spin qubits require.